Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorGökbulut, Cengiz
dc.contributor.authorAkşit, Dilek
dc.contributor.authorSmaldone, Giorgio
dc.contributor.authorMariani, Ugo
dc.contributor.authorVeneziano, Vincenzo
dc.date.accessioned2019-10-17T07:17:06Z
dc.date.available2019-10-17T07:17:06Z
dc.date.issued2014en_US
dc.identifier.issn0304-4017
dc.identifier.issn1873-2550
dc.identifier.urihttps://doi.org/10.1016/j.vetpar.2014.06.026
dc.identifier.urihttps://hdl.handle.net/20.500.12462/7589
dc.descriptionAkşit, Dilek (Balıkesir author)en_US
dc.description.abstractThe plasma disposition, faecal excretion and efficacy of two formulations of pyrantel pamoate in donkeys were examined in a controlled trial. Three groups of seven donkeys received either no medication (control) or pyrantel paste or granule formulations at horse dosage of 20 mg/kg B.W. (equals 6.94 mg/kg PYR base) of body weight. Heparinized blood and faecal samples were collected at various times between 1 and 144 h after treatment. The samples were analysed by high-performance liquid chromatography. The last detectable plasma concentration (t(max)) of paste formulation was significantly earlier (36.00 h) compared with granule formulation (46.29 h). Although, there was no significant difference on terminal half lives (t(1/2): 12.39 h vs. 14.86 h), t(max) (14.86 h vs. 14.00) and MRT (24.80h vs. 25.44h) values; the C-max (0.09 mu g/ml) AUC (2.65 mu g h/ml) values of paste formulation were significantly lower and smaller compared with those of granule formulation (0.21 mu g/ml and 5.60 mu g h/ml), respectively. The highest dry faecal concentrations were 710.46 mu g/g and 537.21 mu g/g and were determined at 48 h for both paste and granule formulation of PYR in donkeys, respectively. Pre-treatment EPG of 1104, 1061 and 1139 were observed for the control, PYR paste and PYR granule groups, respectively. Pre-treatment EPG were not significantly different (P> 0.1) between groups. Post-treatment EPG for both PYR treatment groups were significantly different (P< 0.001) from the control group until day 35. Following treatments the PYR formulations were efficient (>95% efficacy) until day 28. In all studied donkeys, coprocultures performed at day-3 revealed the presence of Cyathostomes, S. vulgaris. Faecal cultures performed on different days from C-group confirmed the presence of the same genera. Coprocultures from treated animals revealed the presence of few larvae of Cyathostomes.en_US
dc.description.sponsorshipMinistry of Health of the Italian Republic IZSME 14/11 RCen_US
dc.language.isoengen_US
dc.publisherElsevier Science Bven_US
dc.relation.isversionof10.1016/j.vetpar.2014.06.026en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPharmacokineticsen_US
dc.subjectEfficacyen_US
dc.subjectPyrantelen_US
dc.subjectPasteen_US
dc.subjectGranuleen_US
dc.subjectDonkeyen_US
dc.titlePlasma pharmacokinetics, faecal excretion and efficacy of pyrantel pamoate paste and granule formulations following per os administration in donkeys naturally infected with intestinal strongylidaeen_US
dc.typearticleen_US
dc.relation.journalVeterinary Parasitologyen_US
dc.contributor.departmentVeteriner Fakültesien_US
dc.contributor.authorID0000-0002-4912-7307en_US
dc.contributor.authorID0000-0003-2496-4034en_US
dc.contributor.authorID0000-0003-3136-597Xen_US
dc.identifier.volume205en_US
dc.identifier.issue1-2en_US
dc.identifier.startpage186en_US
dc.identifier.endpage192en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster